EEG PROFILE STUDIES OF CLOZAPINE IN VOLUNTEERS AND PSYCHIATRIC PATIENTSFINK M; IRVIN P; WEINHOLD P et al.1979; PHARMAKOPSYCHIATR. NEURO-PSYCHOPHARMAKOL.; DEU; DA. 1979; VOL. 12; NO 2; PP. 184-190; ABS. GER; BIBL. 29 REF.Article

A PROPOS DE LAQUESTION DES EFFETS SECONDAIRES DU CLOZAPINVENCOVSKY E; PETEROVA E; BAUDIS P et al.1976; CESKOSL. PSYCHIATR.; CESKOSL.; DA. 1976; VOL. 72; NO 1; PP. 4-6; ABS. RUSSE ANGL.Article

CLOZAPINE IN THE TREATMENT OF NEWLY ADMITTED SCHIZOPHRENIC PATIENTS. A PILOT STUDYCHOUINARD G; ANNABLE L.1976; J. CLIN. PHARMACOL.; U.S.A.; DA. 1976; VOL. 16; NO 5-6; PP. 289-297; BIBL. 13 REF.Article

NEUROLEPTIC ACTION OF CLOZAPINE INJECTED INTO VARIOUS BRAIN AREAS IN RATS = L'ACTION NEUROLEPTIQUE DE LA CLOZAPINE INJECTEE DANS DIVERSES AIRES DU CERVEAU CHEZ DES RATSFOG R.1975; INTERNATION. PHARMACOPSYCHIATRY; SWITZ.; DA. 1975; VOL. 10; NO 2; PP. 89-93; BIBL. 14REF.Article

CLOZAPINE AND THE DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA, A CRITICAL APPRAISALBURKI HR; EICHENBERGER E; SAYERS AC et al.1975; PHARMAKOPSYCHIATR. NEURO-PSYCHOPHARMAKOL.; DTSCH.; DA. 1975; VOL. 8; NO 3; PP. 115-121; ABS. ALLEM.; BIBL. 1P.1/2Article

Controlled release of clozapine through chitosan microparticles prepared by a novel methodAGNIHOTRI, Sunil A; AMINABHAVI, Tejraj M.Journal of controlled release. 2004, Vol 96, Num 2, pp 245-259, issn 0168-3659, 15 p.Article

ETUDE CLINIQUE EN "DOUBLE BLIND" DU HF 1854 (=LX100-129=CLOZAPINE-LEPONEX) COMPARE A L'HALOPERIDOLCIUREZU T; IONESCU R; UDANGIU SN et al.1976; REV. ROUMAINE MED., NEUROL. PSYCHIATR.; ROUMAN.; DA. 1976; VOL. 14; NO 1; PP. 29-34; ABS. ANGL.; BIBL. 8 REF.Article

A PSYCHOPHYSIOLOGICAL INVESTIGATION OF THE SHORT-TERM OF ELOZAPINE UPON SHEEP PARAMETERS OF NORMAL YOUNG ADULTS.TOUYZ SW; BEUMONT PJV; SAAYMAN GS et al.1977; BIOL. PSYCHIATRY; U.S.A.; DA. 1977; VOL. 12; NO 6; PP. 801-822; BIBL. 1 P. 1/2Article

EXPERIENCIA CON EL LEPONEX. = RESULTATS OBTENUS AVEC LE LEPONEXGOTOR DIAZ DP; BARAS VALENZUELA DM.1975; ACTAS LUSO-ESP. NEUROL. PSIQUIATR. CI. AFINES; ESP.; DA. 1975; VOL. 3; NO 4; PP. 281-286; ABS. ANGL.; BIBL. 7 REF.Article

EXTRAPYRAMIDALE SYMPTOME UNTER CLOZAPIN. EIN KASUISTISCHER BEITRAG. = SIGNES EXTRAPYRAMIDAUX SOUS CLOZAPIN. UN CAS RAPPORTE (LEPONEX)DOEPP S; BUDDEBERG C.1975; NERVENARZT; DTSCH.; DA. 1975; VOL. 46; NO 10; PP. 589-590; BIBL. 9 REF.Article

THE EFFECTS OF CLOZAPINE, THIORIDAZINE AND PHENOXYBENZAMINE ON THE ACTION OF DRUGS STIMULATING THE CENTRAL CATECHOLAMINE RECEPTORS = EFFETS DE LA CLOZAPINE, LA THIORIDAZINE ET DE LA PHENOXYBENZAMINE SUR L'ACTION DE SUBSTANCES STIMULANT LES RECEPTEURS CENTRAUX CATECHOLAMINERGIQUESMAJ J; SOWINSKA H; BARAN L et al.1974; POLISH J. PHARMACOL. PHARM.; POLAND; DA. 1974; VOL. 26; NO 4; PP. 437-448; ABS. POL.; BIBL. 27REF.Article

BEZIEHUNGEN ZWISCHEN WIRKUNGEN UND PLASMASPIEGELN VON CLOZAPIN = RAPPORTS ENTRE LES ACTIVITES ET LES TAUX PLASMATIQUES DE CLOZAPINEBRAU H; BURKHART A; PACHA W et al.1978; ARZNEIMITTEL-FORSCH.; DEU; DA. 1978; VOL. 28; NO 8; PP. 1300; ABS. ENG; BIBL. 3 REF.Article

ETUDE ELECTROCHIMIQUE ET DIFFERENCIATION DE DERIVES DES DIBENZODIAZEPINES ET DES DIBENZOTHIAZEPINESVIRE JC; PATRIARCHE GJ; PATRIARCHE SEPULCHRE J et al.1978; ANAL. LETTERS; USA; DA. 1978; VOL. B11; NO 9; PP. 681-695; ABS. ENG; BIBL. 14 REF.Article

DETECTION OF THE NEUROLEPTIC PROPERTIES OF CLOZAPINE, SULPIRIDE AND THIORIDAZINE. = DETECTION DE PROPRIETES NEUROLEPTIQUES DE LA CLOZAPINE, DU SULPIRIDE ET DE LA THIORIDAZINECOSTALL B; NAYLOR RJ.1975; PSYCHOPHARMACOLOGIA; ALLEM.; DA. 1975; VOL. 43; NO 1; PP. 69-74; BIBL. 28 REF.Article

DIFFERENTIAL SENSITIVITY TO AMPHETAMINE FOLLOWING LONG-TERM TREATMENT WITH CLOZAPINE OR HALOPERIDOLREBEC GV; PEIRSON EE; MCPHERSON FA et al.1982; PSYCHOPHARMACOLOGIA; ISSN 0033-3158; DEU; DA. 1982; VOL. 77; NO 4; PP. 360-366; BIBL. 30 REF.Article

DOPAMINE METABOLISM IN THE NUCLEUS ACCUMBENS: THE EFFECT OF CLOZAPINEWILK S; GLICK SD.1976; EUROP. J. PHARMACOL.; NETHERL.; DA. 1976; VOL. 37; NO 1; PP. 203-206; BIBL. 10 REF.Article

EFFECTS OF A SINGLE ADMINISTRATION OF CLOZAPINE ON MOUSE BRAIN CATECHOLAMINESHYTTEL J.1976; ACTA PHARMACOL. TOXICOL.; DANEM.; DA. 1976; VOL. 38; NO 4; PP. 358-365; BIBL. 16 REF.Article

AUFFAELLIGE EEG-VERAENDERUNGEN UNTER CLOZAPIN-BEHANDLUNG BEI PARANOID-HALLUZINATORISCHEN PSYCHOSENISERMANN H; HAUPT R.1976; NERVENARZT; DTSCH.; DA. 1976; VOL. 47; NO 4; PP. 268Article

INHIBITION OF TURNING BEHAVIOUR BY CLOZAPINE IN MICE WITH UNILATERAL DESTRUCTION OF DOPAMINERGIC NERVE TERMINALS = INHIBITION DU COMPORTEMENT DE ROTATION PAR LA CLOZAPINE CHEZ DES SOURIS AVEC DESTRUCTION UNILATERALE DES TERMINAISONS NERVEUSES DOPAMINERGIQUESPYCOCK CJ; TARSY D; MARSDEN CD et al.1975; J. PHARM. PHARMACOL.; G.B.; DA. 1975; VOL. 27; NO 6; PP. 445-447; BIBL. 20REF.Article

CLOZAPINE. A NEW ANTIPSYCHOTIC AGENT = LA CLOZAPINE. UN NOUVEL AGENT ANTIPSYCHOTIQUESIMPSON GM; PSYCH MRC; VARGA E et al.PSYCH MRC; 1974; CURR. THERAPEUT. RES.; U.S.A.; DA. 1974; VOL. 16; NO 7; PP. 679-686; BIBL. 9REF.Article

High clozapine concentrations in leukocytes in a patient who developed leukocytopeniaBERGEMANN, Niels; ABU-TAIR, Fatima; ADERJAN, Rolf et al.Progress in neuro-psychopharmacology & biological psychiatry. 2007, Vol 31, Num 5, pp 1068-1071, issn 0278-5846, 4 p.Article

PAROXYSMAL EEG ACTIVITY AND PSYCHOPATHOLOGY DURING THE TREATMENT WITH CLOZAPINEKOUKKOU M; ANGST J; ZIMMER D et al.1979; PHARMAKOPSYCHIATR. NEURO-PSYCHOPHARMAKOL.; DEU; DA. 1979; VOL. 12; NO 2; PP. 173-183; ABS. GER; BIBL. 28 REF.Article

EFFECT OF SINGLE AND REPEATED ADMINISTRATION OF CLOZAPINE ON THE METABOLISM OF DOPAMINE AND NORADRENALINE IN THE BRAIN OF THE RAT = EFFET DE L'ADMINISTRATION UNIQUE ET REPETEE DE CLOZAPINE SUR LE METABOLISME DE LA DOPAMINE ET DE LA NORADRENALINE DANS LE CERVEAU DU RATBURKI HR; RUCH W; ASPER H et al.1974; EUROP. J. PHARMACOL.; NETHERL.; DA. 1974; VOL. 27; NO 2; PP. 180-190; BIBL. 1P1/2Article

EFFECTS OF CLOZAPINE ON CEREBRAL CATECHOLAMINERGIC NEURONE SYSTEMSBARTHOLINI G; HAEFELY W; JALFRE M et al.1972; BRIT. J. PHARMACOL.; G.B.; DA. 1972; VOL. 46; NO 4; PP. 736-740; BIBL. 13 REF.Serial Issue

The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variationLINGJUN ZUO; XINGGUANG LUO; KRYSTAL, John H et al.Pharmacogenetics and genomics (Print). 2009, Vol 19, Num 6, pp 437-446, issn 1744-6872, 10 p.Article